Basic Information
Basic information for LINC01821-202-48aa
Peptide Name LINC01821-202-48aa
Genome Position chr2:194344271-194344319,194368841-194368935[+]
Species Human
Peptide Sequence MQHKNFRDRRNLPLRAVIHLCEILKSEKSKVELTSRCKSTTNKQKWQC
Peptide Length 48
Unique No (LINC01821-203-48aa,LINC01821-206-48aa,LINC01821-208-48aa,LINC01821-209-48aa,LINC01821-211-48aa)
Grand Average of Hydropathicity -1.0125
Relative Molecular Mass 6630.6
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000225539;LINC01821
Transcript ID/Name ENST00000438505;LINC01821-202
Transcript Length 882
Coding Ability 0.3186
DNA Sequence Corresponding to Peptide ATGCAACATAAAAATTTCAGAGACAGAAGAAATCTTCCTTTGAGGGCAGTGATACACTTATGTGAGATTTTGAAAAGTGAAAAATCAAAGGTGGAATTGACCAGTAGATGTAAAAGTACAACAAATAAACAAAAATGGCAATGT
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :